Amarin Corporation plc (AMRN) shares are up more than 14% to $2.72 in early trading. The move comes on a big volume too with the issue currently trading more than 13.6 million shares, compared to the average volume of 4.4 million shares. The stock began trading this morning at $2.30 to currently trade 35 cents higher from the prior days close of $2.37. On an intraday basis it gotten as low as $2.27 and as high as $2.77. Not seeing any news or rumors to account for the move.
On valuation measures, the T-12 profit margin at Amarin Corporation is (103.99%). AMRN‘s revenue for the same period is $54.20 million. The name’s current year and next year EPS growth estimates stand at 31.60% and 56.40% compared to the industry growth rates of (9.60%) and (92.80%), respectively. AMRN has a t-12 price/sales ratio of 7.63. EPS for the same period registers at ($0.36).
AMRN shares have advanced 100.85% in the last 4 weeks and 119.44% in the past three months. Over the past 5 trading sessions the stock has gained 27.42%. Shares of Amarin Corporation plc are up 141.91% this year.
The Dublin, Ireland-based biopharmaceutical firm, which is currently valued at $469.65 million, has a median Wall Street price target of $6.00 with a high target of $10.00. AMRN is up 33.90% year-over-year, compared with an 11.47 % gain in the S&P 500.